MktsMarkets

Aytu BioPharma, Inc.
NASDAQ: AYTUKey statistics
AYTU News
Stories mentioning AYTU from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 12,411 | 15,165 | 13,888 | 15,135 | 18,452 | 16,221 | 16,574 | 14,593 |
| Cost of Goods Sold | 4,812 | 5,541 | 4,702 | 4,881 | 5,646 | 5,435 | 4,589 | 3,541 |
| Gross Profit | 7,599 | 9,624 | 9,186 | 10,254 | 12,806 | 10,786 | 11,985 | 11,052 |
| Operating Expenses | ||||||||
| Research & Development | 0.00 | 0.00 | 0.00 | 216.00 | 162.00 | 522.00 | 426.00 | 1,042 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 11,663 | 11,594 | 10,690 | 17,877 | 10,385 | 12,481 | 12,915 | 13,325 |
| Operating Income (Loss) | (4,064) | (1,970) | (1,504) | (7,623) | 2,421 | (1,695) | (930.00) | (2,273) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 149.00 | 190.00 | 201.00 | (1,230) | 36.00 | 140.00 | 542.00 | 120.00 |
| Pretax Income | (5,608) | (10,584) | 1,965 | (19,443) | 3,818 | 382.00 | 1,498 | (2,537) |
| Tax Provision | 10.00 | 0.00 | 0.00 | 437.00 | (122.00) | (283.00) | 405.00 | 841.00 |
| Net Income (Loss) | (5,618) | (10,584) | 1,965 | (19,818) | 3,994 | 788.00 | 1,474 | (4,617) |
| Earnings Per Share (Basic) | (0.53) | (1.05) | 0.21 | (3.16) | 0.65 | 0.13 | 0.24 | (0.83) |
| Earnings Per Share (Diluted) | (0.53) | (1.05) | (0.08) | 0.21 | (0.26) | (0.15) | ||
| Weighted Average Shares Outstanding (Basic) | 10,512 | 10,036 | 9,441 | 6,280 | 6,135 | 6,132 | 6,068 | 5,538 |
| Weighted Average Shares Outstanding (Diluted) | 10,512 | 10,036 | 19,477 | 8,204 | 8,485 | 9,100 | ||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AYTU
Aytu BioPharma, Inc. (NASDAQ: AYTU) is a stock listed on the Nasdaq Stock Market under the ticker symbol AYTU. It last traded at $1.90 (Oct 27, 2026, 4:00 PM ET), down 1.6% on the day. That gives Aytu BioPharma a market capitalisation of $21.1M.
Over the past 52 weeks AYTU has traded between $1.80 and $3.06.
Revenue for the quarter ended Mar 31, 2026 was $12.4M; a net loss of $5.6M. Revenue was down 32.7% from $18.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $12.4M | -$5.6M | -45.3% |
| Dec 31, 2025 | $15.2M | -$10.6M | -69.8% |
| Sep 30, 2025 | $13.9M | $2.0M | 14.1% |
| Jun 30, 2025 | $15.1M | -$19.8M | -130.9% |
From Aytu BioPharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…